What is the recommended pediatric sedation regimen for a child undergoing a CT scan?

Pediatric Sedation for CT Scan

For pediatric CT scans, use oral chloral hydrate (50 mg/kg for infants <1 year) or intramuscular pentobarbital (5 mg/kg for children >1 year) as first-line agents, with intravenous midazolam (0.2 mg/kg) as an effective alternative when IV access is available. 1

Sedation Goals and Safety Framework

The primary goals when sedating children for CT imaging are to guard patient safety, minimize discomfort, control anxiety, and provide appropriate cardiopulmonary support if needed. 1

Critical safety principle: Children commonly pass from the intended sedation level to a deeper, unintended level. Practitioners must have rescue skills for one level deeper than intended—if planning moderate sedation, you must be able to rescue from deep sedation; if planning deep sedation, you must be able to rescue from general anesthesia. 1

Patient Selection

• ASA I-II patients are appropriate candidates for minimal, moderate, or deep sedation 1
• ASA III-IV patients, children with special needs, anatomic airway abnormalities, or moderate-to-severe tonsillar hypertrophy require additional individual consideration and heightened vigilance 1

Recommended Sedation Regimens

First-Line Agents

Oral chloral hydrate remains the most frequently used first-line drug for pediatric CT sedation across most practice settings. 2

• Infants <1 year: Oral chloral hydrate 50 mg/kg 3
• Children >1 year: Intramuscular pentobarbital 5 mg/kg 3
• This protocol achieved satisfactory scans in 98% of patients (343/350) after a single dose or initial dose with supplementation 3

Alternative: Intravenous Midazolam

When IV access is available, midazolam 0.2 mg/kg IV is highly effective as a sole agent. 4

• Additional boluses of 0.1 mg/kg (maximum total 0.5 mg/kg) can be given if needed 4
• Achieves adequate sedation in 90.12% of patients within 5.9 ± 0.7 minutes 4
• Peak EEG effect occurs at approximately 4.8 minutes—wait for full effect before administering additional doses 1
• Only 2.13% of procedures could not be completed satisfactorily 4
• Side effects minimal: desaturation (6.93%) corrected with supplemental oxygen, hiccups (1.38%), agitation (0.79%) 4

Drugs to Avoid

Promethazine (Phenergan) has a black box warning for fatal respiratory depression in children <2 years and should be avoided. 1

Long-acting agents (intramuscular pentobarbital at higher doses, phenothiazines) have fallen out of favor due to unpredictable responses, prolonged recovery, and risk of re-sedation after discharge—particularly dangerous for infants in car safety seats. 1

Special Populations

Neonates and Former Preterm Infants

• Require specific management due to immature hepatic and renal function, which prolongs drug metabolism and necessitates extended post-sedation monitoring 1
• Former preterm infants have increased risk of post-anesthesia apnea 1
• Avoid unnecessary sedation if the procedure is unlikely to change medical management (e.g., screening MRI in preterm infants) 1

Monitoring Requirements

During Sedation

• Continuous pulse oximetry (required) 1
• Heart rate monitoring (required) 1
• Blood pressure (required) 1
• Respiratory monitoring (required) 1
• Capnography recommended for moderate sedation, required for deep sedation 1
• ECG recommended for moderate sedation, required for deep sedation 1
• Document vital signs every 5 minutes during deep sedation, every 10 minutes during moderate sedation 1

Equipment Requirements

• Suction equipment, adequate oxygen source/supply, and defibrillator required 1
• Rescue cart properly stocked with age- and size-appropriate equipment and rescue drugs 1
• Personnel must have PALS training and skills in airway management, intubation, and cardiopulmonary resuscitation 1

Recovery and Discharge

• Dedicated recovery area with monitoring personnel required 1
• Initial vital signs recorded at least every 10 minutes until child begins to awaken, then intervals may be increased 1
• Observe for at least 1 hour post-procedure 4
• Critical caveat: Watch for re-sedation after discharge, especially with longer-acting agents in infants transported in car safety seats 1
• Child must be accompanied by parent, legal guardian, or responsible adult; preferably two adults for children still in car safety seats 1

Practical Considerations

Newer dual-source CT scanners (1-3 second acquisition time vs. 12 seconds with conventional scanners) have reduced sedation requirements from 8% to 7% of patients, particularly decreasing the need for deep sedation. 5 This technology advancement should be considered when available, as it improves safety by reducing sedation exposure.

Non-pharmacologic alternatives should be considered first: parental presence, distraction, electronic devices with age-appropriate games/videos, guided imagery, and child life specialist techniques may reduce or eliminate the need for pharmacologic sedation. 1